{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:57:53Z","timestamp":1781459873420,"version":"3.54.1"},"reference-count":146,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["534642099"],"award-info":[{"award-number":["534642099"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.biopsych.2026.01.021","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:48:28Z","timestamp":1771865308000},"page":"713-727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Timing Matters: Leveraging Positron Emission Tomography Imaging and Hormonal Cycles for Precision Psychiatry in Female Mental Health"],"prefix":"10.1016","volume":"99","author":[{"given":"Emily","family":"May","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Comasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solveig","family":"Tiepolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Strau\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Kundakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swen","family":"Hesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Sabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"Villringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0944-0558","authenticated-orcid":false,"given":"Julia","family":"Sacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2026.01.021_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13293-014-0017-3","article-title":"Sex differences in mood disorders: Perspectives from humans and rodent models","volume":"5","author":"Seney","year":"2014","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.biopsych.2026.01.021_bib2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00012272-200510000-00008","article-title":"Estrogen-related mood disorders: Reproductive life cycle factors","volume":"28","author":"Douma","year":"2005","journal-title":"Adv Nurs Sci"},{"key":"10.1016\/j.biopsych.2026.01.021_bib3","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1038\/s41467-022-29903-3","article-title":"An analysis of neuroscience and psychiatry papers published from 2009 and 2019 outlines opportunities for increasing discovery of sex differences","volume":"13","author":"Rechlin","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2026.01.021_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13293-022-00466-8","article-title":"Why the estrous cycle matters for neuroscience","volume":"13","author":"Rocks","year":"2022","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.biopsych.2026.01.021_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105168","article-title":"Towards understanding the biology of premenstrual dysphoric disorder: From genes to GABA","volume":"149","author":"Hantsoo","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2026.01.021_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11920-015-0628-3","article-title":"Premenstrual dysphoric disorder: Epidemiology and treatment","volume":"17","author":"Hantsoo","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.biopsych.2026.01.021_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1176\/appi.ajp.2012.11081302","article-title":"Premenstrual dysphoric disorder: Evidence for a new category for DSM-5","volume":"169","author":"Epperson","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-024-00495-0","article-title":"Attention-deficit\/hyperactivity disorder","volume":"10","author":"Faraone","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.biopsych.2026.01.021_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2022.103205","article-title":"Gender-based differences in prevalence and effects of ADHD in adults: A systematic review","volume":"75","author":"Faheem","year":"2022","journal-title":"Asian J Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/jcpp.13480","article-title":"Annual research review: Attention-deficit\/hyperactivity disorder in girls and women: Underrepresentation, longitudinal processes, and key directions","volume":"63","author":"Hinshaw","year":"2022","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1306194","article-title":"Female-specific pharmacotherapy in ADHD: Premenstrual adjustment of psychostimulant dosage","volume":"14","author":"De Jong","year":"2023","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib12","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.3390\/jcm13072106","article-title":"A female-specific treatment group for ADHD: Description of the programme and qualitative analysis of first experiences","volume":"13","author":"De Jong","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.biopsych.2026.01.021_bib13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/jclp.20121","article-title":"Treating adolescent girls and women with ADHD: Gender-specific issues","volume":"61","author":"Quinn","year":"2005","journal-title":"J Clin Psychol"},{"key":"10.1016\/j.biopsych.2026.01.021_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111261","article-title":"The effects of psychostimulants in menstruating women with ADHD\u2014a gender health gap in ADHD treatment?","volume":"137","author":"Findeis","year":"2025","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2020.100878","article-title":"Neuroimaging the menstrual cycle: A multimodal systematic review","volume":"60","author":"Dubol","year":"2021","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.biopsych.2026.01.021_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2024.101174","article-title":"Estrogens and human brain networks: A systematic review of structural and functional neuroimaging studies","volume":"77","author":"Ruehr","year":"2025","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.biopsych.2026.01.021_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2019.104655","article-title":"A brief guide to the menstrual cycle and oral contraceptive use for researchers in behavioral endocrinology","volume":"119","author":"Hampson","year":"2020","journal-title":"Horm Behav"},{"key":"10.1016\/j.biopsych.2026.01.021_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1363875","article-title":"Premenstrual syndrome: New insights into etiology and review of treatment methods","volume":"15","author":"Modzelewski","year":"2024","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199801223380401","article-title":"Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome","volume":"338","author":"Schmidt","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2026.01.021_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1192\/bjp.2025.40","article-title":"Differential sensitivity: Not more or less","volume":"226","author":"Rubinow","year":"2025","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib21","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1176\/appi.ajp.159.11.1876","article-title":"Effects of metergoline on symptoms in women with premenstrual dysphoric disorder","volume":"159","author":"Roca","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1348551","article-title":"The impact of estradiol on serotonin, glutamate, and dopamine systems","volume":"18","author":"Bendis","year":"2024","journal-title":"Front Neurosci"},{"key":"10.1016\/j.biopsych.2026.01.021_bib23","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.3390\/ijms20225729","article-title":"An association of serotonin with pain disorders and its modulation by estrogens","volume":"20","author":"Paredes","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.biopsych.2026.01.021_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fpubh.2018.00141","article-title":"Steroid hormones and their action in women\u2019s brains: The importance of hormonal balance","volume":"6","author":"Del R\u00edo","year":"2018","journal-title":"Front Public Health"},{"key":"10.1016\/j.biopsych.2026.01.021_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fnins.2015.00037","article-title":"Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods","volume":"9","author":"Barth","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1016\/j.biopsych.2026.01.021_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1140796","article-title":"Role of allopregnanolone-mediated \u03b3-aminobutyric acid A receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development","volume":"14","author":"Gao","year":"2023","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41398-025-03465-6","article-title":"Transcription of GABAA receptor subunits in circulating monocytes and association to emotional brain function in premenstrual dysphoric disorder","volume":"15","author":"Stiernman","year":"2025","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.psyneuen.2016.10.024","article-title":"A specific profile of luteal phase progesterone is associated with the development of premenstrual symptoms","volume":"75","author":"Lovick","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopsych.2026.01.021_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40263-023-01004-9","article-title":"New pharmacological approaches to the management of premenstrual dysphoric disorder","volume":"37","author":"Sundstr\u00f6m-Poromaa","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopsych.2026.01.021_bib30","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/npp.2015.246","article-title":"5\u03b1-reductase inhibition prevents the luteal phase increase in plasma allopregnanolone levels and mitigates symptoms in women with premenstrual dysphoric disorder","volume":"41","author":"Martinez","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.01.021_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psyneuen.2017.11.015","article-title":"Reproductive steroids and ADHD symptoms across the menstrual cycle","volume":"88","author":"Roberts","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopsych.2026.01.021_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2023.105466","article-title":"Attention-deficit\/hyperactivity disorder and the menstrual cycle: Theory and evidence","volume":"158","author":"Eng","year":"2024","journal-title":"Horm Behav"},{"key":"10.1016\/j.biopsych.2026.01.021_bib33","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1177\/10870547251355006","article-title":"Examining the link between ADHD symptoms and menopausal experiences","volume":"29","author":"Chapman","year":"2025","journal-title":"J Atten Disord"},{"key":"10.1016\/j.biopsych.2026.01.021_bib34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jpsychires.2020.12.005","article-title":"Prevalence of hormone-related mood disorder symptoms in women with ADHD","volume":"133","author":"Dorani","year":"2021","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2026.01.021_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1492126","article-title":"The dopamine hypothesis for ADHD: An evaluation of evidence accumulated from human studies and animal models","volume":"15","author":"MacDonald","year":"2024","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib36","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1523\/JNEUROSCI.6394-10.2011","article-title":"Estrogen shapes dopamine-dependent cognitive processes: Implications for women\u2019s health","volume":"31","author":"Jacobs","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.01.021_bib37","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/10870547251332319","article-title":"ADHD and sex hormones in females: A systematic review","volume":"29","author":"Osianlis","year":"2025","journal-title":"J Atten Disord"},{"key":"10.1016\/j.biopsych.2026.01.021_bib38","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2012.11.031","article-title":"Chronic estradiol-17\u03b2 exposure suppresses hypothalamic norepinephrine release and the steroid-induced luteinizing hormone surge: Role of nitration of tyrosine hydroxylase","volume":"1493","author":"Kasturi","year":"2013","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2026.01.021_bib39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1365-2826.2010.02086.x","article-title":"Varied mechanisms of oestradiol-mediated regulation of dopamine \u03b2-hydroxylase transcription","volume":"23","author":"Serova","year":"2011","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.biopsych.2026.01.021_bib40","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1093\/brain\/awab111","article-title":"The role of noradrenaline in cognition and cognitive disorders","volume":"144","author":"Holland","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2026.01.021_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109897","article-title":"Novel pharmacological targets for GABAergic dysfunction in ADHD","volume":"249","author":"Ferranti","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2026.01.021_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12565","article-title":"Sex steroid hormones and brain function: PET imaging as a tool for research","volume":"30","author":"Moraga-Amaro","year":"2018","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.biopsych.2026.01.021_bib43","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1186\/s12888-025-07533-5","article-title":"Trait- versus state-grey matter volume alterations in premenstrual dysphoric disorder","volume":"25","author":"Stiernman","year":"2025","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib44","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.neuroimage.2011.12.037","article-title":"PET radiotracers for molecular imaging in the brain: Past, present and future","volume":"61","author":"Zimmer","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2026.01.021_bib45","doi-asserted-by":"crossref","first-page":"414","DOI":"10.23736\/S1824-4785.17.03019-9","article-title":"News and views on in-vivo imaging of neurotransmission using PET and MRI","volume":"61","author":"Sander","year":"2017","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.biopsych.2026.01.021_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2022.101007","article-title":"Can animal models resemble a premenstrual dysphoric condition?","volume":"66","author":"Erika","year":"2022","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.biopsych.2026.01.021_bib47","series-title":"Principles of Gender-Specific Medicine","first-page":"453","article-title":"The invaluable contribution of animal models in understanding sex-dependent differences in neuropsychiatric disorders","author":"Fattore","year":"2023"},{"key":"10.1016\/j.biopsych.2026.01.021_bib48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pscychresns.2008.07.002","article-title":"5-HT1A receptor and 5-HTT binding during the menstrual cycle in healthy women examined with [11C]WAY100635 and [11C]MADAM PET","volume":"172","author":"Jovanovic","year":"2009","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10.1016\/j.biopsych.2026.01.021_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0925-4927(98)00021-3","article-title":"A PET study of D2 dopamine receptor density at different phases of the menstrual cycle","volume":"83","author":"Nordstr\u00f6m","year":"1998","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10.1016\/j.biopsych.2026.01.021_bib50","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.biopsych.2015.04.015","article-title":"Role of serotonin transporter changes in depressive responses to sex-steroid hormone manipulation: A positron emission tomography study","volume":"78","author":"Frokjaer","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib51","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1176\/appi.ajp.160.8.1522","article-title":"Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women","volume":"160","author":"Kugaya","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib52","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0006-3223(00)00967-7","article-title":"Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: A PET study","volume":"48","author":"Moses","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib53","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0015-0282(03)00973-7","article-title":"Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women","volume":"80","author":"Moses-Kolko","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.biopsych.2026.01.021_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.799675","article-title":"The impact of hormonal contraceptive use on serotonergic neurotransmission and antidepressant treatment response: Results from the NeuroPharm 1 study","volume":"13","author":"Larsen","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.biopsych.2026.01.021_bib55","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.neuroscience.2009.06.052","article-title":"Gender and the use of hormonal contraception in women are not associated with cerebral cortical 5-HT2A receptor binding","volume":"163","author":"Frokjaer","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2026.01.021_bib56","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/acps.13211","article-title":"Oral contraceptives and the serotonin 4 receptor: A molecular brain imaging study in healthy women","volume":"142","author":"Larsen","year":"2020","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2026.01.021_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.104895","article-title":"How to study the menstrual cycle: Practical tools and recommendations","volume":"123","author":"Schmalenberger","year":"2021","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopsych.2026.01.021_bib58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clinbiochem.2020.03.008","article-title":"Advancements in the gold standard: Measuring steroid sex hormones by mass spectrometry","volume":"82","author":"Conklin","year":"2020","journal-title":"Clin Biochem"},{"key":"10.1016\/j.biopsych.2026.01.021_bib59","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1158\/1055-9965.EPI-09-0643","article-title":"Comparison of liquid chromatography\u2013tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens","volume":"19","author":"Faupel-Badger","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.biopsych.2026.01.021_bib60","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.pscychresns.2006.05.002","article-title":"A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria","volume":"148","author":"Jovanovic","year":"2006","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10.1016\/j.biopsych.2026.01.021_bib61","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.biopsych.2022.12.023","article-title":"Increase in serotonin transporter binding in patients with premenstrual dysphoric disorder across the menstrual cycle: A case-control longitudinal neuroreceptor ligand positron emission tomography imaging study","volume":"93","author":"Sacher","year":"2023","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib62","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1038\/s41380-020-01000-1","article-title":"Striatal dopamine D2-type receptor availability and peripheral 17\u03b2-estradiol","volume":"26","author":"Petersen","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pscychresns.2005.02.012","article-title":"Mood changes correlate to changes in brain serotonin precursor trapping in women with premenstrual dysphoria","volume":"146","author":"Eriksson","year":"2006","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10.1016\/j.biopsych.2026.01.021_bib64","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00259-010-1663-2","article-title":"Measuring serotonin synthesis: From conventional methods to PET tracers and their (pre)clinical implications","volume":"38","author":"Visser","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.biopsych.2026.01.021_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159538","article-title":"Women with premenstrual dysphoria lack the seemingly normal premenstrual right-sided relative dominance of 5-HTP-derived serotonergic activity in the dorsolateral prefrontal cortices\u2014a possible cause of disabling mood symptoms","volume":"11","author":"Eriksson","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2026.01.021_bib66","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jpsychires.2024.05.024","article-title":"Functional and structural neuroimaging in premenstrual dysphoric disorder: A systematic review","volume":"175","author":"Monteiro","year":"2024","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2026.01.021_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108447","article-title":"Molecular imaging of the serotonin transporter availability and occupancy by antidepressant treatment in late-life depression","volume":"194","author":"Smith","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2026.01.021_bib68","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.biopsych.2023.04.013","article-title":"A role for the serotonin transporter in the largely unknown molecular pathophysiology of premenstrual dysphoric disorder","volume":"93","author":"Meyer","year":"2023","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib69","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11604-022-01368-w","article-title":"Positron emission tomography studies in adult patients with attention-deficit\/hyperactivity disorder","volume":"41","author":"Yamamoto","year":"2023","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.biopsych.2026.01.021_bib70","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/appi.ajp.2011.11060940","article-title":"Striatal dopamine transporter alterations in ADHD: Pathophysiology or adaptation to psychostimulants? A meta-analysis","volume":"169","author":"Fusar-Poli","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib71","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/ejn.14067","article-title":"Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study","volume":"48","author":"Wiers","year":"2018","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2026.01.021_bib72","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1586\/14737175.8.4.611","article-title":"SPECT and PET of the dopamine transporter in attention-deficit\/hyperactivity disorder","volume":"8","author":"Krause","year":"2008","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.biopsych.2026.01.021_bib73","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jama.2009.1308","article-title":"Evaluating dopamine reward pathway in attention-deficit\/hyperactivity disorder","volume":"302","author":"Volkow","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2026.01.021_bib74","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.neuroimage.2004.11.031","article-title":"Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder","volume":"25","author":"Rosa-Neto","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2026.01.021_bib75","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1523\/JNEUROSCI.4461-11.2012","article-title":"Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder","volume":"32","author":"Volkow","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.01.021_bib76","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41380-021-01294-9","article-title":"Sex differences in methylphenidate-induced dopamine increases in ventral striatum","volume":"27","author":"Manza","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib77","article-title":"Long-term stimulant treatment affects brain dopamine transporter level in patients with attention-deficit hyperactivity disorder","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2026.01.021_bib78","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jamapsychiatry.2014.1226","article-title":"The norepinephrine transporter in attention-deficit\/hyperactivity disorder investigated with positron emission tomography","volume":"71","author":"Vanicek","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib79","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41398-019-0619-y","article-title":"Adult attention-deficit\/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: an (S,S)-O-[11C]methylreboxetine positron emission tomography study","volume":"9","author":"Ulke","year":"2019","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib80","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41380-019-0461-x","article-title":"Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity\u2013impulsivity symptoms in ADHD measured with PET","volume":"26","author":"Sigurdardottir","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib81","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s00259-016-3590-3","article-title":"Central noradrenaline transporter availability in highly obese, non-depressed individuals","volume":"44","author":"Hesse","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.biopsych.2026.01.021_bib82","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/ijo.2015.216","article-title":"The central nervous norepinephrine network links a diminished sense of emotional well-being to an increased body weight","volume":"40","author":"Melasch","year":"2016","journal-title":"Int J Obes"},{"key":"10.1016\/j.biopsych.2026.01.021_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239257","article-title":"The female side of pharmacotherapy for ADHD\u2014a systematic literature review","volume":"15","author":"Kok","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2026.01.021_bib84","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neulet.2018.08.010","article-title":"Positron emission tomography imaging of the \u03b3-aminobutyric acid system","volume":"691","author":"Andersson","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2026.01.021_bib85","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/npp.2014.190","article-title":"Relationship of monoamine oxidase-A distribution volume to postpartum depression and postpartum crying","volume":"40","author":"Sacher","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.01.021_bib86","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/jamapsychiatry.2014.250","article-title":"Greater monoamine oxidase A binding in perimenopausal age as measured with carbon-11\u2013labeled harmine positron emission tomography","volume":"71","author":"Rekkas","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib87","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/09540261.2017.1397607","article-title":"Using positron emission tomography to investigate hormone-mediated neurochemical changes across the female lifespan: Implications for depression","volume":"29","author":"Zsido","year":"2017","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib88","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.biopsych.2024.02.105","article-title":"Elevated MAOA and altered bioenergetics underlying elevated emotionality and treatment resistance in depression","volume":"95","author":"Lebeau","year":"2024","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2023.101081","article-title":"The historical progression of positron emission tomography research in neuroendocrinology","volume":"70","author":"Bini","year":"2023","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.biopsych.2026.01.021_bib90","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2967\/jnumed.114.150383","article-title":"Aromatase imaging with [N-methyl-11C]vorozole PET in healthy men and women","volume":"56","author":"Biegon","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2026.01.021_bib91","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1002\/jnr.24707","article-title":"Quantification of aromatase binding in the female human brain using [11C]cetrozole positron emission tomography","volume":"98","author":"Jonasson","year":"2020","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.biopsych.2026.01.021_bib92","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac197","article-title":"Nuclear receptor imaging in vivo\u2014clinical and research advances","volume":"7","author":"Parent","year":"2023","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.biopsych.2026.01.021_bib145","doi-asserted-by":"crossref","first-page":"12680","DOI":"10.1038\/s41598-024-62820-7","article-title":"In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology","volume":"14","author":"Mosconi","year":"2024","journal-title":"Scientific Reports"},{"key":"10.1016\/j.biopsych.2026.01.021_bib146","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00259-025-07470-1","article-title":"Quantification and simplified [18F] fluoroestradiol positron emission tomography (PET) measures of brain estrogen receptor expression","volume":"53","author":"Nerattini","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.biopsych.2026.01.021_bib93","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2967\/jnumed.124.268782","article-title":"No in vivo evidence for estrogen receptor density changes in human neuroendocrine aging or their relationship to cognition and menopausal symptoms","volume":"65","author":"Biegon","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2026.01.021_bib94","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s11307-020-01520-w","article-title":"Cross-species physiological assessment of brain estrogen receptor expression using 18F-FES and 18F-4FMFES PET imaging","volume":"22","author":"Paquette","year":"2020","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.biopsych.2026.01.021_bib95","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2967\/jnumed.119.228858","article-title":"Recent advances in imaging steroid hormone receptors in breast cancer","volume":"61","author":"Kumar","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2026.01.021_bib96","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3390\/biom13091405","article-title":"Peering into the brain\u2019s estrogen receptors: PET tracers for visualization of nuclear and extranuclear estrogen receptors in brain disorders","volume":"13","author":"Arjmand","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopsych.2026.01.021_bib97","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2147\/IJWH.S297062","article-title":"Management of premenstrual dysphoric disorder: A scoping review","volume":"14","author":"Carlini","year":"2022","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.biopsych.2026.01.021_bib98","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/npp.2008.86","article-title":"Short onset of action of a serotonin reuptake inhibitor when used to reduce premenstrual irritability","volume":"34","author":"Land\u00e9n","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.01.021_bib99","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/da.21959","article-title":"Rapid response to fluoxetine in women with premenstrual dysphoric disorder","volume":"29","author":"Steinberg","year":"2012","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.biopsych.2026.01.021_bib100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/02698811221099645","article-title":"Intermittent selective serotonin reuptake inhibitors for premenstrual syndromes: A systematic review and meta-analysis of randomised trials","volume":"37","author":"Reilly","year":"2023","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2026.01.021_bib101","article-title":"Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder","volume":"8","author":"Jespersen","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.biopsych.2026.01.021_bib102","article-title":"Oral contraceptives containing drospirenone for premenstrual syndrome","volume":"6","author":"Ma","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.biopsych.2026.01.021_bib103","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ajog.2021.06.090","article-title":"Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: Pairwise and network meta-analysis of randomized trials","volume":"225","author":"De Wit","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.biopsych.2026.01.021_bib104","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/jog.15618","article-title":"Current status and problems in the diagnosis and treatment of premenstrual syndrome and premenstrual dysphoric disorder from the perspective of obstetricians and gynecologists in Japan","volume":"49","author":"Yoshimi","year":"2023","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.biopsych.2026.01.021_bib105","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12905-023-02334-y","article-title":"Exploring diagnosis and treatment of premenstrual dysphoric disorder in the U.S. healthcare system: A qualitative investigation","volume":"23","author":"Chan","year":"2023","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.biopsych.2026.01.021_bib106","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1471-0528.2004.00135.x","article-title":"The effectiveness of GnRHa with and without add-back therapy in treating premenstrual syndrome: A meta-analysis","volume":"111","author":"Wyatt","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.biopsych.2026.01.021_bib107","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.psyneuen.2017.02.031","article-title":"Treatment of premenstrual dysphoric disorder with the GABAA receptor-modulating steroid antagonist sepranolone (UC1010): A randomized controlled trial","volume":"80","author":"Bixo","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopsych.2026.01.021_bib108","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1176\/appi.ajp.2020.20030286","article-title":"Ulipristal acetate for treatment of premenstrual dysphoric disorder: A proof-of-concept randomized controlled trial","volume":"178","author":"Comasco","year":"2021","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.479646","article-title":"Steroid hormone sensitivity in reproductive mood disorders: On the role of the GABAA receptor complex and stress during hormonal transitions","volume":"7","author":"Schweizer-Schubert","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.biopsych.2026.01.021_bib110","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11920-021-01286-0","article-title":"Premenstrual exacerbations of mood disorders: Findings and knowledge gaps","volume":"23","author":"Kuehner","year":"2021","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.biopsych.2026.01.021_bib111","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1192\/bjp.2025.104","article-title":"Increased risk of provisional premenstrual dysphoric disorder among females with attention-deficit hyperactivity disorder: Cross-sectional survey study","volume":"226","author":"Broughton","year":"2025","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib112","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.psyneuen.2012.11.006","article-title":"Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill: A double-blinded, placebo-controlled randomized trial","volume":"38","author":"Gingnell","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopsych.2026.01.021_bib113","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s40261-020-00966-8","article-title":"Hormonal contraception and depression: Updated evidence and implications in clinical practice","volume":"40","author":"Fruzzetti","year":"2020","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.biopsych.2026.01.021_bib114","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41398-022-02294-1","article-title":"Effects of acute estradiol and progesterone on perimenstrual exacerbation of suicidal ideation and related symptoms: A crossover randomized controlled trial","volume":"12","author":"Eisenlohr-Moul","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib115","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00737-016-0631-7","article-title":"Fourth consensus of the International Society for Premenstrual Disorders: Auditable standards for diagnosis and management of premenstrual disorder","volume":"19","author":"Consensus Group of the International Society for Premenstrual Disorders","year":"2016","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.biopsych.2026.01.021_bib116","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5455\/msm.2021.33.114-118","article-title":"ADHD symptoms in females of childhood, adolescent, reproductive and menopause period","volume":"33","author":"Antoniou","year":"2021","journal-title":"Mater Sociomed"},{"key":"10.1016\/j.biopsych.2026.01.021_bib117","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s43045-025-00508-y","article-title":"Gender disparities in ADHD medication efficacy: Investigating treatment outcomes for females compared to males","volume":"32","author":"Amiri","year":"2025","journal-title":"Middle East Curr Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib118","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0091-3057(02)00818-3","article-title":"Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phase","volume":"73","author":"White","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2026.01.021_bib119","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1177\/10870547251315601","article-title":"A review of sex and gender factors in stimulant treatment for ADHD: Knowledge gaps and future directions","volume":"29","author":"Rapoport","year":"2025","journal-title":"J Atten Disord"},{"key":"10.1016\/j.biopsych.2026.01.021_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2025.1568088","article-title":"Editorial: Psychiatric illness across the menstrual cycle","volume":"16","author":"Hantsoo","year":"2025","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib121","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1192\/bjp.2025.10298","article-title":"Psychiatric symptoms on the ovarian hormone roller-coaster","volume":"226","author":"Comasco","year":"2025","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib122","doi-asserted-by":"crossref","DOI":"10.1136\/bmjment-2024-301463","article-title":"The menstrual cycle: An overlooked vital sign in psychiatry?","volume":"28","author":"Marwick","year":"2025","journal-title":"BMJ Ment Health"},{"key":"10.1016\/j.biopsych.2026.01.021_bib123","first-page":"5","article-title":"Premenstrual disorders: A primer and research agenda for psychologists","volume":"72","author":"Eisenlohr-Moul","year":"2019","journal-title":"Clin Psychol"},{"key":"10.1016\/j.biopsych.2026.01.021_bib124","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00737-022-01246-4","article-title":"Premenstrual exacerbation of mental health disorders: A systematic review of prospective studies","volume":"25","author":"Nolan","year":"2022","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.biopsych.2026.01.021_bib125","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1037\/abn0000304","article-title":"Interactive effects of ovarian steroid hormones on alcohol use and binge drinking across the menstrual cycle","volume":"126","author":"Martel","year":"2017","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/j.biopsych.2026.01.021_bib126","doi-asserted-by":"crossref","first-page":"910220","DOI":"10.3389\/fgwh.2022.910220","article-title":"Menstrual cycle in trauma-related disorders: A mini-review","volume":"3","author":"Mu","year":"2022","journal-title":"Front Glob Womens Health"},{"key":"10.1016\/j.biopsych.2026.01.021_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.948219","article-title":"Ovarian steroid hormones: A long overlooked but critical contributor to brain aging and Alzheimer\u2019s disease","volume":"14","author":"Jett","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.biopsych.2026.01.021_bib128","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.fertnstert.2007.03.059","article-title":"Serotonin 1A receptor reductions in postpartum depression: A positron emission tomography study","volume":"89","author":"Moses-Kolko","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.biopsych.2026.01.021_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2014.03.004","article-title":"Effects of hormone replacement therapy on cerebral serotonin-1A receptor binding in postmenopausal women examined with [carbonyl-11C]WAY-100635","volume":"45","author":"Kranz","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopsych.2026.01.021_bib130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.psyneuen.2014.04.008","article-title":"Relation of progesterone and DHEAS serum levels to 5-HT1A receptor binding potential in pre- and postmenopausal women","volume":"46","author":"Stein","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopsych.2026.01.021_bib131","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neulet.2010.04.020","article-title":"Hypothalamic serotonin-1A receptor binding measured by PET predicts the plasma level of dehydroepiandrosterone sulfate in healthy women","volume":"476","author":"Moser","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2026.01.021_bib132","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hbm.23418","article-title":"Altered interregional molecular associations of the serotonin transporter in attention deficit\/hyperactivity disorder assessed with PET","volume":"38","author":"Vanicek","year":"2017","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.biopsych.2026.01.021_bib133","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41398-020-0781-2","article-title":"Machine learning classification of ADHD and healthy controls by multimodal serotonergic data","volume":"10","author":"Kautzky","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib134","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.3389\/fpsyg.2018.02767","article-title":"Negative association between allopregnanolone and cerebral serotonin transporter binding in healthy women of fertile age","volume":"9","author":"Sundstr\u00f6m Poromaa","year":"2019","journal-title":"Front Psychol"},{"key":"10.1016\/j.biopsych.2026.01.021_bib135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1192\/bjp.2018.234","article-title":"Evidence for oestrogen sensitivity in perinatal depression: Pharmacological sex hormone manipulation study","volume":"215","author":"Mehta","year":"2019","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib136","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.biopsych.2014.09.010","article-title":"High-dose testosterone treatment increases serotonin transporter binding in transgender people","volume":"78","author":"Kranz","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib137","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.pscychresns.2013.02.001","article-title":"Serotonin transporter in attention-deficit hyperactivity disorder\u2014preliminary results from a positron emission tomography study","volume":"212","author":"Karlsson","year":"2013","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10.1016\/j.biopsych.2026.01.021_bib138","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/npp.2011.328","article-title":"Postpartum and depression status are associated with lower [11C]raclopride binding potential in reproductive-age women","volume":"37","author":"Moses-Kolko","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.01.021_bib139","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/archpsyc.64.8.932","article-title":"Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit\/hyperactivity disorder","volume":"64","author":"Volkow","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib140","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.biopsych.2005.03.036","article-title":"In vivo neuroreceptor imaging in attention-deficit\/hyperactivity disorder: A focus on the dopamine transporter","volume":"57","author":"Spencer","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib141","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.biopsych.2006.12.008","article-title":"Further evidence of dopamine transporter dysregulation in ADHD: A controlled PET imaging study using altropane","volume":"62","author":"Spencer","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.01.021_bib142","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1523\/JNEUROSCI.18-15-05901.1998","article-title":"DOPA decarboxylase activity in attention deficit hyperactivity disorder adults: A [18F]fluorodopa positron emission tomographic study","volume":"18","author":"Ernst","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.01.021_bib143","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/hbm.23071","article-title":"Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET","volume":"37","author":"Sigurdardottir","year":"2016","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.biopsych.2026.01.021_bib144","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/archgenpsychiatry.2010.32","article-title":"Elevated brain monoamine oxidase A binding in the early postpartum period","volume":"67","author":"Sacher","year":"2010","journal-title":"Arch Gen Psychiatry"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000632232600065X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000632232600065X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:16:17Z","timestamp":1781457377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000632232600065X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":146,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S000632232600065X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2026.01.021","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Timing Matters: Leveraging Positron Emission Tomography Imaging and Hormonal Cycles for Precision Psychiatry in Female Mental Health","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2026.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc on behalf of Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}